Rare
lephants
Screener
Toggle theme
Arcus Biosciences, Inc.
RCUS
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2022
FY2020
Total Cash from Operations:
$471.0M
Line Item
Value
% of Total
Capital Expenditures
$6.0M
1.3%
Other Investing
$407.0M
86.4%
Net Cash Flow
$58.0M
12.3%
Download CSV
